体外MIMIC®平台反映流感疫苗接种后免疫应答的年龄相关变化
研究利用全自体人细胞体外MIMIC®平台,评估老年人与成人接种三价流感疫苗后的免疫应答差异。结果显示老年人株特异性IgG产量较成人降低2.7-4.2倍,功能性抗体生成随年龄下降,TIV特异性多功能CD4+ T细胞数量减少但比例不变。
要点
- MIMIC®平台可体外重现流感疫苗接种后年龄相关的抗体和T细胞应答差异。
- 老年人对TIV的株特异性IgG产量较成人降低2.7-4.2倍。
- 老年人TIV特异性多功能CD4+ T细胞数量减少但比例不变。
核心结论
- MIMIC®系统能够在体外重现年龄相关的差异应答,为在全人模型包括特定人群如老年人中测试候选疫苗和疫苗增强策略提供了动态平台。
研究设计与样本
- 研究采用全自体人细胞为基础的MIMIC®(模块化体外免疫构建)平台,对老年人和成人的细胞进行体外流感疫苗接种,并比较免疫应答。
- 同一队列中,通过体内TIV接种后短期离体刺激B细胞检测IgG产量。
主要发现
- 在MIMIC®系统中,老年人对季节性三价流感疫苗(TIV)的株特异性IgG产量较成人降低2.7-4.2倍。
- MIMIC®中观察到功能性抗体生成随年龄增长而下降。
- 同一队列体内TIV接种后短期离体刺激B细胞,检测到IgG产量随年龄增长平行下降。
- MIMIC®中老年人TIV特异性多功能CD154+IFNγ+IL-2+TNFα+ CD4+ T细胞数量减少,但比例不变。
- 尽管初始CD4+ T细胞数量正常,MIMIC®中TIV刺激诱导多功能辅助T细胞效率低下,提示老年人抗TIV IgG应答受损的可能机制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Increasing research and development costs coupled with growing concerns over healthcare expenditures necessitate the generation of pre-clinical testing models better able to predict the efficacy of vaccines, drugs and biologics. An ideal system for evaluating vaccine immunogenicity will not only be reliable but also physiologically relevant, able to be influenced by immunomodulatory characteristics such as age or previous exposure to pathogens. We have previously described a fully autologous human cell-based MIMIC® (Modular IMmune In vitro Construct) platform which enables the evaluation of innate and adaptive immunity in vitro, including naïve and recall responses. Here, we establish the ability of this module to display reduced antibody production and T cell activation upon in vitro influenza vaccination of cells from elderly adults. In the MIMIC® system, we observe a 2.7-4.2-fold reduction in strain-specific IgG production to seasonal trivalent influenza vaccine (TIV) in the elderly when compared to adults, as well as an age-dependent decline in the generation of functional antibodies. A parallel decline in IgG production with increasing age was detected via short-term ex vivo stimulation of B cells after in vivo TIV vaccination in the same cohort. Using MIMIC®, we also detect a reduction in the number but not proportion of TIV-specific multifunctional CD154+IFNγ+IL-2+TNFα+ CD4+ T cells in elderly adults. Inefficient induction of multifunctional helper T cells with TIV stimulation in MIMIC® despite a normalized number of initial CD4+ T cells suggests a possible mechanism for an impaired anti-TIV IgG response in elderly adults. The ability of the MIMIC® system to recapitulate differential age-associated responses in vitro provides a dynamic platform for the testing of vaccine candidates and vaccine enhancement strategies in a fully human model including the ability to interrogate specific populations, such as elderly adults.
引用
- Dauner A, Agrawal P, Salvatico J, et al. The in vitro MIMIC® platform reflects age-associated changes in immunological responses after influenza vaccination. Vaccine. 2017. PMID: 28413134. doi:10.1016/j.vaccine.2017.03.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。